The company is providing several of its Parsortix instruments to the CANCER-ID consortium as part of an effort to establish liquid biopsy in routine clinical practice.
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
The agency is sending an Oxford Nanopore MinIon to the International Space Station to determine if the technology's microfluidic system can work in microgravity.
The aim of the project, called Metafluidics, is to replace cumbersome conventional approaches with a cheaper, faster, and higher-throughput microfluidics platform.
Fluidic Analytics, a Cambridge University spinout, has licensed the technology and plans to commercialize an instrument for the research market in mid-2016.
The new device rotates heating blocks to contact a stationary sample and is meant to be integrated with a plug-and-play digital microfluidics hub.
NeoPrep combines electrowetting technology that Illumina acquired when it purchased Advanced Liquid Logic in 2013 with microfluidics.
The UK Biobank will use Trinean's technology to quantify molecules during the DNA extraction stage of a large genotyping project.
NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said today that they will collaborate in the area of cancer diagnostics.
NEW YORK (GenomeWeb) – UK-based microfluidics developer Dolomite will sell Sphere Fluidics' products under a distribution deal announced by the two firms this week.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.